Ensuring safety first: GLP‐1RAs in reproductive and endometrial research

Ensuring safety first: GLP‐1RAs in reproductive and endometrial research

Saved in:

Bibliographic Details
Main Authors:	Paola Viganò, Maira Casalechi, Andrea Salonia, Edgardo Somigliana
Format:	Article
Language:	English
Published:	Wiley 2025-05-01
Series:	Acta Obstetricia et Gynecologica Scandinavica
Online Access:	https://doi.org/10.1111/aogs.15060
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Indeed, safety comes first for the use of GLP‐1RAs
by: Amruta D. S. Pathare, et al.
Published: (2025-05-01)

Probability of second live birth after first natural and medically assisted reproduction‐mediated live birth: A historical cohort study
by: Giovanna Esposito, et al.
Published: (2024-01-01)

Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
by: Xu He, et al.
Published: (2025-01-01)

Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity
by: Andrew Overholser, et al.
Published: (2025-02-01)

Patients’ experiences with GLP1-RAs – a systematic review
by: Christoffer Kraul Ibsen, et al.
Published: (2025-04-01)

Epigenetic age and fertility timeline: testing an epigenetic clock to forecast in vitro fertilization success rate
by: Davide Marinello, et al.
Published: (2025-07-01)

Assessing GLP-1 RAs in Diabetic Gastroparesis: A Literature Review
by: Jacob Itkin, et al.
Published: (2025-06-01)

Clarifying methodological approaches in the assessment of GLP-1 RAs and gastrointestinal cancer risk
by: Gisella Figlioli, et al.
Published: (2024-12-01)

The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation
by: Alberto Sola‐Leyva, et al.
Published: (2025-02-01)

Therapeutic potential of GLP-1RAs in sleep apnea with genetic associations to type 2 diabetes
by: Fang Cheng, et al.
Published: (2025-04-01)

Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis
by: Long He, et al.
Published: (2025-02-01)

Risk factor screening and prediction modeling of gastrointestinal adverse reactions caused by GLP-1RAs
by: Rui Gao, et al.
Published: (2024-12-01)

Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations
by: Dan Xu, et al.
Published: (2022-01-01)

Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning
by: Jung A Kim, et al.
Published: (2025-07-01)

Stronger Together: How GLP-1 RAs and SGLT-2 Inhibitors Revolutionize Type 2 Diabetes Treatment
by: Hanna Sitarek, et al.
Published: (2025-05-01)

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?
by: Lampros Chrysavgis, et al.
Published: (2025-06-01)

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cardiometabolic protection: historical development and future challenges
by: Francisco Westermeier, et al.
Published: (2025-01-01)

Association of GLP1RAs with risk of chronic obstructive pulmonary disease: evidence from drug target Mendelian randomization
by: Sijia Lai, et al.
Published: (2025-07-01)

Correction: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cardiometabolic protection: historical development and future challenges
by: Francisco Westermeier, et al.
Published: (2025-03-01)

The Impact and Safety of GLP‐1 Agents and Breast Cancer
by: Kayla Parsons, et al.
Published: (2025-06-01)

The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review
by: Michael Nunns, et al.
Published: (2025-06-01)

Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide
by: Yuki Oe, et al.
Published: (2025-05-01)

Improving Reproductive Outcomes in PCOS: The Emerging Role of GLP-1 Receptor Agonists
by: Adrianna Tabeau, et al.
Published: (2025-03-01)

The Impact of GLP-1 Receptor Agonists on Women's Reproductive Health: A Review
by: Marta Wolszczak, et al.
Published: (2025-06-01)

GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
by: Wu Li, et al.
Published: (2024-12-01)

What Are the Experiences, Views and Perceptions of Patients, Carers and Clinicians of Glucagon‐like Peptide‐1 Receptor Agonists (GLP‐1 RAs)? A Scoping Review
by: Sam Febrey, et al.
Published: (2025-04-01)

WCN24-1330 EFFECTS OF SGLT2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS ON TOP OF RAS BLOCKADE IN UNINEFRECTOMIZED DB/DB MICE
by: María José Soler, et al.
Published: (2024-04-01)

Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study
by: Allen Cheng-Wei Li, et al.
Published: (2025-01-01)

Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study.
by: Allen Cheng-Wei Li, et al.
Published: (2025-01-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Anti-Inflammatory and Anti-Oxidative Effects of GLP1-RAs and SGLT2i: The Guiding Star Towards Cardiovascular Protection in Type 2 Diabetes
by: Livia M. R. Marcon, et al.
Published: (2025-03-01)

Endometrial morphology in women of reproductive age with PCOS
by: E. M. Sharifulin, et al.
Published: (2018-05-01)

Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis
by: Li Yang, et al.
Published: (2021-01-01)

Predicting the risk of malignisation of endometrial hyperplasia in reproductive age
by: I. M. Ordiyants, et al.
Published: (2020-03-01)

GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity
by: Vijay Kumar
Published: (2025-07-01)

Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federation
by: O. K. Vikulova, et al.
Published: (2022-03-01)

Ensuring the effectiveness and safety of peripheral blockades
by: I. G. Oleshchenko, et al.
Published: (2021-12-01)

BASIC ASPECTS ENSURING SHIPPING SAFETY
by: Oleksiy MELNYK, et al.
Published: (2022-12-01)

Could Increased Glp1r Expression via Sitagliptin in the GLP-1/GLP-1 Receptor Axis in the DietInduced Obesity Rat Model be Important in Liver Metabolism?
by: Cem Horozoğlu, et al.
Published: (2024-12-01)

Repository of SPSTL SB RAS Research Data
by: T. A. Kalyuzhnaya, et al.
Published: (2024-11-01)